Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03OMK
|
|||
Former ID |
DIB001757
|
|||
Drug Name |
DM-107
|
|||
Synonyms |
MDPK-67; MDPK-67b; Kallikrein 2 inhibitor (anticancer), Med Discovery; Kallikrein 2 inhibitor (dermatological disorders), Dermadis
Click to Show/Hide
|
|||
Indication | Atopic dermatitis [ICD-11: EA80; ICD-10: L20; ICD-9: 691.8, 692.9] | Investigative | [1] | |
Company |
Med Discovery SA
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Tissue kallikrein (KLK2) | Target Info | Inhibitor | [1] |
KEGG Pathway | Endocrine and other factor-regulated calcium reabsorption | |||
NetPath Pathway | IL2 Signaling Pathway | |||
Pathway Interaction Database | Coregulation of Androgen receptor activity | |||
Regulation of Androgen receptor activity | ||||
Reactome | Activation of Matrix Metalloproteinases | |||
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | ||||
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | ||||
WikiPathways | Prostate Cancer |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2372). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.